Left Brain Wealth Management, LLC Abb Vie Inc. Transaction History
Left Brain Wealth Management, LLC
- $284 Billion
- Q2 2025
A detailed history of Left Brain Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Left Brain Wealth Management, LLC holds 3,745 shares of ABBV stock, worth $854,609. This represents 0.24% of its overall portfolio holdings.
Number of Shares
3,745
Previous 3,970
5.67%
Holding current value
$854,609
Previous $832 Million
16.43%
% of portfolio
0.24%
Previous 0.36%
Shares
11 transactions
Others Institutions Holding ABBV
# of Institutions
4,375Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.52 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $403B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...